Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

cabazitaxel

cabazitaxel
  • Restricted Anti-Neoplastic Formulary
  • Restricted Jevtana --> Restricted to Oncology and approval from administration prior to use.
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Jevtana SOLUTION, INTRAVENOUS 60 mg/1.5 mL      
VIEW MORE Antineoplastic Agents
CLASS
100000
Comments:

It was classified as a formulary agent, restricted to oncology, not generally stocked.  Defer initiation of therapy to outpatient setting, if possible. Requires administration approval.

Reviewed: August 24, 2010

Last updated: Mar. 5, 2025
Rhazdrugs cabazitaxel






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved